Hailing from California, Dr. Fahy holds a Bachelor of Science degree in Biology from the University of California at Irvine and a Ph.D. from the Medical College of Georgia in Augusta. Dr. Fahy used to be the Head of the Tissue Cryopreservation Section of the Transfusion and Cryopreservation Research Program for the U.S. Naval Medical Research Institute in Bethesda, Maryland, where he developed the original concept of ice blocking agents.
Dr. Fahy is the Chief Scientific Officer and co-founder of Intervene Immune, a biotech company researching rejuvenation of the immune system, particularly the thymus. He designed and led the TRIIM trial, published the first report of thymus regeneration in a normal human, and granted patents on methods for and applications of human thymus regeneration. Before his time at 21st Century Medicine, where he is the Executive Director and Chief Scientific Officer, Dr. Fahy pioneered the practical use of cryopreservation by vitrification and invented a computer system to apply this technology to organs at the American Red Cross.
With over 30 years of experience in cryobiology, Dr. Fahy is considered a world expert in organ cryopreservation by vitrification. He introduced the modern successful approach to vitrification for the cryopreservation process to cryobiology, and also managed to prove that restoration of organ function after cryopreservation is possible. He was awarded the Society for Cryobiology’s Luyet Medal in 2016 and in 2009, he showed indefinite survival of rabbit kidney transplanted after cooling to -130° Celsius. He led the 21CM team as the co-winner of the Small Mammal Brain Preservation Prize and is the 2018 winner of the Large Mammal Brain Preservation Prize.
Dr. Fahy is also a biogerontologist and is the originator and Editor-in-Chief of The Future of Aging: Pathways to Human Life Extension, a multi-authored book about the future of biogerontology.
For 16 years, Dr. Fahy worked as a Director of the American Aging Association and for 6 years as the editor of AGE News, the organization’s newsletter. He currently serves on the editorial boards of Rejuvenation Research and the Open Geriatric Medicine Journal.